- Home
- ELDN vs COOK Comparison
ELDN vs COOK Comparison
Compare ELDN & COOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- COOK
- Stock Information
- Founded
- ELDN 2004
- COOK 1985
- Country
- ELDN United States
- COOK United States
- Employees
- ELDN N/A
- COOK N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- COOK Wholesale Distributors
- Sector
- ELDN Health Care
- COOK Consumer Discretionary
- Exchange
- ELDN Nasdaq
- COOK Nasdaq
- Market Cap
- ELDN 232.4M
- COOK 237.8M
- IPO Year
- ELDN N/A
- COOK 2021
- Fundamental
- Price
- ELDN $3.22
- COOK $1.65
- Analyst Decision
- ELDN Strong Buy
- COOK Hold
- Analyst Count
- ELDN 1
- COOK 6
- Target Price
- ELDN $16.00
- COOK $2.83
- AVG Volume (30 Days)
- ELDN 261.7K
- COOK 224.3K
- Earning Date
- ELDN 05-08-2025
- COOK 03-06-2025
- Dividend Yield
- ELDN N/A
- COOK N/A
- EPS Growth
- ELDN N/A
- COOK N/A
- EPS
- ELDN N/A
- COOK N/A
- Revenue
- ELDN N/A
- COOK $604,072,000.00
- Revenue This Year
- ELDN N/A
- COOK $6.07
- Revenue Next Year
- ELDN N/A
- COOK $9.17
- P/E Ratio
- ELDN N/A
- COOK N/A
- Revenue Growth
- ELDN N/A
- COOK N/A
- 52 Week Low
- ELDN $1.52
- COOK $1.62
- 52 Week High
- ELDN $5.54
- COOK $3.97
- Technical
- Relative Strength Index (RSI)
- ELDN 30.78
- COOK 25.00
- Support Level
- ELDN $3.22
- COOK $1.70
- Resistance Level
- ELDN $3.45
- COOK $1.89
- Average True Range (ATR)
- ELDN 0.19
- COOK 0.11
- MACD
- ELDN -0.01
- COOK 0.01
- Stochastic Oscillator
- ELDN 7.01
- COOK 12.76
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.